FDA Drug recall D-0672-2016
Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA
- FDA Drug
- Class I
- terminated
- Published 2016-02-24
On 2016-02-24 the FDA classified a Class I recall of Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA by Premiere Sales Group, citing marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0672-2016 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2015-09-30 |
| Published | 2016-02-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Premiere Sales Group |
| Distribution | US |
Product
Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA
Reason
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Identifiers
| code_info | All lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0672-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.